Literature DB >> 19750060

Heparin-induced thrombocytopenia: overview and treatment.

Daniel A Zinkovsky, Marilena S Antonopoulos.   

Abstract

Entities:  

Year:  2008        PMID： 19750060      PMCID： PMC2730808     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  29 in total

1.  Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings.

Authors:  G K Lo; D Juhl; T E Warkentin; C S Sigouin; P Eichler; A Greinacher
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

Review 2.  Clinical practice. Heparin-induced thrombocytopenia.

Authors:  Gowthami M Arepally; Thomas L Ortel
Journal:  N Engl J Med       Date:  2006-08-24       Impact factor: 91.245

3.  Drug-induced immune-mediated thrombocytopenia--from purpura to thrombosis.

Authors:  Theodore E Warkentin
Journal:  N Engl J Med       Date:  2007-03-01       Impact factor: 91.245

Review 4.  Heparin-induced thrombocytopenia, a prothrombotic disease.

Authors:  Jerrold H Levy; Marcie J Hursting
Journal:  Hematol Oncol Clin North Am       Date:  2007-02       Impact factor: 3.722

5.  Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3.

Authors:  N Lubenow; P Eichler; T Lietz; A Greinacher
Journal:  J Thromb Haemost       Date:  2005-11       Impact factor: 5.824

Review 6.  Heparin-induced thrombocytopenia in intensive care patients.

Authors:  Kathleen Selleng; Theodore E Warkentin; Andreas Greinacher
Journal:  Crit Care Med       Date:  2007-04       Impact factor: 7.598

7.  Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Theodore E Warkentin; Andreas Greinacher; Andreas Koster; A Michael Lincoff
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

Review 8.  Heparin-induced thrombocytopenia.

Authors:  Theodore E Warkentin
Journal:  Hematol Oncol Clin North Am       Date:  2007-08       Impact factor: 3.722

9.  Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction.

Authors:  Tyree H Kiser; Douglas N Fish
Journal:  Pharmacotherapy       Date:  2006-04       Impact factor: 4.705

Review 10.  Fondaparinux as a treatment option for heparin-induced thrombocytopenia.

Authors:  Stella Papadopoulos; Jeremy D Flynn; Daniel A Lewis
Journal:  Pharmacotherapy       Date:  2007-06       Impact factor: 4.705
View more
  4 in total

1.  Delayed-onset heparin-induced skin necrosis: a rare complication of perioperative heparin therapy.

Authors:  Weh Kiat Gan
Journal:  BMJ Case Rep       Date:  2017-11-03

2.  [Dermal necrosis as cutaneous manifestation of heparin-induced thrombocytopenia II?].

Authors:  M Illes; S Klaus; J C Simon; R Treudler
Journal:  Hautarzt       Date:  2011-04       Impact factor: 0.751

3.  Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirus.

Authors:  Piyanuch Wonganan; Courtney C Clemens; Kathy Brasky; Lucio Pastore; Maria A Croyle
Journal:  Mol Pharm       Date:  2010-09-23       Impact factor: 4.939

Review 4.  Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management.

Authors:  Vasileios Patriarcheas; Antonios Pikoulas; Minas Kostis; Andriani Charpidou; Evangelos Dimakakos
Journal:  Cureus       Date:  2020-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.